Abbott Laboratories Earnings Estimate

ABT Stock

USD 113.48 0.43 0.38%

The next projected EPS of Abbott Laboratories is estimated to be 1.168725 with future projections ranging from a low of 1.165 to a high of 1.175. Abbott Laboratories' most recent 12-month trailing earnings per share (EPS TTM) is at 3.37. Please be aware that the consensus of earnings estimates for Abbott Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Abbott Laboratories is projected to generate 1.168725 in earnings per share on the 31st of December 2024. Abbott Laboratories earnings estimates show analyst consensus about projected Abbott Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Abbott Laboratories' historical volatility. Many public companies, such as Abbott Laboratories, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Abbott Laboratories Revenue Breakdown by Earning Segment

By analyzing Abbott Laboratories' earnings estimates, investors can diagnose different trends across Abbott Laboratories' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Abbott Laboratories' Gross Profit is comparatively stable compared to the past year. Pretax Profit Margin is likely to gain to 0.21 in 2025, whereas Net Profit Margin is likely to drop 0.15 in 2025.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Earnings Estimation Breakdown

The calculation of Abbott Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Abbott Laboratories is estimated to be 1.168725 with the future projection ranging from a low of 1.165 to a high of 1.175. Please be aware that this consensus of annual earnings estimates for Abbott Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

1.21

1.17

Lowest

Expected EPS

1.168725

1.18

Highest

Abbott Laboratories Earnings Projection Consensus

Suppose the current estimates of Abbott Laboratories' value are higher than the current market price of the Abbott Laboratories stock. In this case, investors may conclude that Abbott Laboratories is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Abbott Laboratories' stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of December 2024	Current EPS (TTM)
27	93.25%	1.21		1.168725	3.37

Abbott Laboratories Earnings History

Earnings estimate consensus by Abbott Laboratories analysts from Wall Street is used by the market to judge Abbott Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Abbott Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Abbott Laboratories Quarterly Gross Profit

5.94 Billion

Retained Earnings is likely to gain to about 45.3 B in 2025, whereas Retained Earnings Total Equity is likely to drop slightly above 27.2 B in 2025. Net Income Applicable To Common Shares is likely to gain to about 8.4 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.3 B in 2025.

Hype

Prediction

Low	Estimated	High
112.37	113.42	114.47

Details

Intrinsic

Valuation

Low	Real	High
102.13	122.35	123.40

Details

27 Analysts

Consensus

Low	Target	High
118.87	130.62	144.99

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Abbott Laboratories. Note that many institutional investors and large investment bankers can move markets due to the volume of Abbott assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Abbott Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Abbott Laboratories' stock price in the short term.

Abbott Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of Abbott Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Abbott Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Abbott Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Abbott Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Abbott Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Abbott Laboratories should always be considered in relation to other companies to make a more educated investment decision.

Abbott Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-10-16	2024-09-30	1.2	1.21	0.01	0
2024-07-18	2024-06-30	1.1	1.14	0.04	3
2024-04-17	2024-03-31	0.95	0.98	0.03	3
2024-01-24	2023-12-31	1.19	1.19	0.0	0
2023-10-18	2023-09-30	1.1	1.14	0.04	3
2023-07-20	2023-06-30	1.05	1.08	0.03	2
2023-04-19	2023-03-31	0.99	1.03	0.04	4
2023-01-25	2022-12-31	0.92	1.03	0.11	11
2022-10-19	2022-09-30	0.94	1.15	0.21	22
2022-07-20	2022-06-30	1.13	1.43	0.3	26
2022-04-20	2022-03-31	1.47	1.73	0.26	17
2022-01-26	2021-12-31	1.21	1.32	0.11	9
2021-10-20	2021-09-30	0.95	1.4	0.45	47
2021-07-22	2021-06-30	1.02	1.17	0.15	14
2021-04-20	2021-03-31	1.27	1.32	0.05	3
2021-01-27	2020-12-31	1.35	1.45	0.1	7
2020-10-21	2020-09-30	0.91	0.98	0.07	7
2020-07-16	2020-06-30	0.42	0.57	0.15	35
2020-04-16	2020-03-31	0.58	0.65	0.07	12
2020-01-22	2019-12-31	0.95	0.95	0.0	0
2019-10-16	2019-09-30	0.84	0.84	0.0	0
2019-07-17	2019-06-30	0.8	0.82	0.02	2
2019-04-17	2019-03-31	0.61	0.63	0.02	3
2019-01-23	2018-12-31	0.81	0.81	0.0	0
2018-10-17	2018-09-30	0.75	0.75	0.0	0
2018-07-18	2018-06-30	0.71	0.73	0.02	2
2018-04-18	2018-03-31	0.58	0.59	0.01	1
2018-01-24	2017-12-31	0.73	0.74	0.01	1
2017-10-18	2017-09-30	0.65	0.66	0.01	1
2017-07-20	2017-06-30	0.61	0.62	0.01	1
2017-04-19	2017-03-31	0.43	0.48	0.05	11
2017-01-25	2016-12-31	0.65	0.65	0.0	0
2016-10-19	2016-09-30	0.58	0.59	0.01	1
2016-07-20	2016-06-30	0.53	0.55	0.02	3
2016-04-20	2016-03-31	0.39	0.41	0.02	5
2016-01-28	2015-12-31	0.61	0.62	0.01	1
2015-10-21	2015-09-30	0.53	0.54	0.01	1
2015-07-22	2015-06-30	0.5	0.52	0.02	4
2015-04-22	2015-03-31	0.42	0.47	0.05	11
2015-01-29	2014-12-31	0.68	0.71	0.03	4
2014-10-22	2014-09-30	0.59	0.62	0.03	5
2014-07-16	2014-06-30	0.51	0.54	0.03	5
2014-04-16	2014-03-31	0.36	0.41	0.05	13
2014-01-22	2013-12-31	0.58	0.58	0.0	0
2013-10-16	2013-09-30	0.51	0.55	0.04	7
2013-07-17	2013-06-30	0.44	0.46	0.02	4
2013-04-17	2013-03-31	0.41	0.42	0.01	2
2013-01-23	2012-12-31	1.5	1.51	0.01	0
2012-10-17	2012-09-30	1.28	1.3	0.02	1
2012-07-18	2012-06-30	1.22	1.23	0.01	0
2012-04-18	2012-03-31	1	1.03	0.03	3
2012-01-25	2011-12-31	1.44	1.45	0.01	0
2011-10-19	2011-09-30	1.17	1.18	0.01	0
2011-07-20	2011-06-30	1.11	1.12	0.01	0
2011-04-20	2011-03-31	0.9	0.91	0.01	1
2011-01-26	2010-12-31	1.29	1.3	0.01	0
2010-10-20	2010-09-30	1.04	1.05	0.01	0
2010-07-21	2010-06-30	1	1.01	0.01	1
2010-04-21	2010-03-31	0.8	0.81	0.01	1
2010-01-27	2009-12-31	1.17	1.18	0.01	0
2009-10-14	2009-09-30	0.9	0.92	0.02	2
2009-07-15	2009-06-30	0.89	0.89	0.0	0
2009-04-15	2009-03-31	0.7	0.73	0.03	4
2009-01-21	2008-12-31	1.06	1.06	0.0	0
2008-10-15	2008-09-30	0.77	0.79	0.02	2
2008-07-16	2008-06-30	0.79	0.84	0.05	6
2008-04-16	2008-03-31	0.62	0.63	0.01	1
2008-01-23	2007-12-31	0.92	0.93	0.01	1
2007-10-17	2007-09-30	0.66	0.67	0.01	1
2007-07-18	2007-06-30	0.68	0.69	0.01	1
2007-04-18	2007-03-31	0.52	0.55	0.03	5
2007-01-24	2006-12-31	0.74	0.75	0.01	1
2006-10-18	2006-09-30	0.58	0.58	0.0	0
2006-07-19	2006-06-30	0.57	0.62	0.05	8
2006-04-19	2006-03-31	0.57	0.57	0.0	0
2006-01-25	2005-12-31	0.76	0.76	0.0	0
2005-10-19	2005-09-30	0.58	0.58	0.0	0
2005-07-13	2005-06-30	0.57	0.58	0.01	1
2005-04-12	2005-03-31	0.58	0.58	0.0	0
2005-01-18	2004-12-31	0.67	0.67	0.0	0
2004-10-14	2004-09-30	0.53	0.53	0.0	0
2004-07-09	2004-06-30	0.54	0.54	0.0	0
2004-04-08	2004-03-31	0.56	0.57	0.01	1
2004-01-16	2003-12-31	0.65	0.65	0.0	0
2003-10-09	2003-09-30	0.53	0.53	0.0	0
2003-07-10	2003-06-30	0.52	0.52	0.0	0
2003-04-09	2003-03-31	0.51	0.51	0.0	0
2003-01-16	2002-12-31	0.56	0.55	-0.01	1
2002-10-09	2002-09-30	0.48	0.48	0.0	0
2002-07-11	2002-06-30	0.49	0.49	0.0	0
2002-04-09	2002-03-31	0.54	0.54	0.0	0
2002-01-16	2001-12-31	0.52	0.52	0.0	0
2001-10-10	2001-09-30	0.44	0.44	0.0	0
2001-07-12	2001-06-30	0.45	0.45	0.0	0
2001-04-12	2001-03-31	0.47	0.47	0.0	0
2001-01-16	2000-12-31	0.48	0.48	0.0	0
2000-10-10	2000-09-30	0.42	0.42	0.0	0
2000-07-12	2000-06-30	0.44	0.44	0.0	0
2000-04-11	2000-03-31	0.44	0.44	0.0	0
2000-01-18	1999-12-31	0.43	0.43	0.0	0
1999-10-11	1999-09-30	0.38	0.38	0.0	0
1999-07-09	1999-06-30	0.42	0.42	0.0	0
1999-04-08	1999-03-31	0.43	0.44	0.01	2
1999-01-15	1998-12-31	0.41	0.41	0.0	0
1998-10-08	1998-09-30	0.34	0.34	0.0	0
1998-07-09	1998-06-30	0.37	0.38	0.01	2
1998-04-09	1998-03-31	0.38	0.38	0.0	0
1998-01-16	1997-12-31	0.37	0.37	0.0	0
1997-10-08	1997-09-30	0.31	0.31	0.0	0
1997-07-10	1997-06-30	0.34	0.34	0.0	0
1997-04-09	1997-03-31	0.34	0.35	0.01	2
1997-01-16	1996-12-31	0.33	0.33	0.0	0
1996-10-08	1996-09-30	0.27	0.27	0.0	0
1996-07-10	1996-06-30	0.3	0.3	0.0	0
1996-04-08	1996-03-31	0.29	0.31	0.02	6
1996-01-15	1995-12-31	0.3	0.3	0.0	0
1995-10-09	1995-09-30	0.25	0.24	-0.01	4

About Abbott Laboratories Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Abbott Laboratories earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Abbott Laboratories estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Abbott Laboratories fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	43.2 B	45.3 B
Retained Earnings Total Equity	40.5 B	27.2 B
Earnings Yield	0.03	0.03
Price Earnings Ratio	30.02	17.26
Price Earnings To Growth Ratio	(2.36)	(2.24)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Laboratories Earnings Estimate

Abbott Laboratories Revenue Breakdown by Earning Segment

Abbott Laboratories Earnings Estimation Breakdown

Abbott Laboratories Earnings Projection Consensus

Abbott Laboratories Earnings History

Abbott Laboratories Quarterly Gross Profit

5.94 Billion

Abbott Laboratories Earnings per Share Projection vs Actual

Abbott Laboratories Estimated Months Earnings per Share

Abbott Quarterly Analyst Estimates and Surprise Metrics

About Abbott Laboratories Earnings Estimate

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Abbott Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY